Literature DB >> 8952589

Brain "ouabain" and angiotensin II in salt-sensitive hypertension in spontaneously hypertensive rats.

B S Huang1, F H Leenen.   

Abstract

Spontaneously hypertensive rats (SHR) received from 5 to 9 weeks of age a high or regular sodium diet and concomitant intracerebroventricular infusions via minipumps of the following compounds: antibody Fab fragments (200 micrograms/d), which bind ouabain and related steroids with high affinity; the angiotensin II (Ang II) type 1 receptor blocker losartan (1 mg/kg per day); a combination of Fab fragments and losartan; and as control, gamma-globulins (200 micrograms/d). The same doses of Fab fragments and losartan were also given intravenously. At 9 weeks of age, compared with SHR on regular sodium, SHR on high sodium that were treated with gamma-globulins had higher resting blood pressure and showed significantly enhanced excitatory responses of blood pressure, renal sympathetic nerve activity, and heart rate to air stress and inhibitory responses to the central alpha 2-agonist guanabenz. Central Fab fragments and losartan alone or combined prevented all these effects of high sodium. Intravenous Fab fragments or losartan was ineffective. Compared with control SHR on high sodium, SHR on high sodium that were treated with Fab fragments had significantly increased sympathoexcitatory and pressor responses to central Ang II injection, consistent with a decrease in brain Ang II receptor occupancy. These data indicate that both increased brain "ouabain" and Ang II contribute to salt-sensitive hypertension in SHR. Brain Ang II receptor stimulation appears to be downstream of "ouabain" in the pathways mediating sympathoexcitatory and pressor effects of high sodium.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8952589     DOI: 10.1161/01.hyp.28.6.1005

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  16 in total

Review 1.  Central sympathoinhibitory effects of calcium channel blockers.

Authors:  F H Leenen; M Ruzicka; B S Huang
Journal:  Curr Hypertens Rep       Date:  2001-08       Impact factor: 5.369

Review 2.  Central neuromodulatory pathways regulating sympathetic activity in hypertension.

Authors:  Alexander Gabor; Frans H H Leenen
Journal:  J Appl Physiol (1985)       Date:  2012-07-05

Review 3.  Endogenous digitalis: pathophysiologic roles and therapeutic applications.

Authors:  Alexei Y Bagrov; Joseph I Shapiro
Journal:  Nat Clin Pract Nephrol       Date:  2008-06-10

Review 4.  Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

Authors:  Alexei Y Bagrov; Joseph I Shapiro; Olga V Fedorova
Journal:  Pharmacol Rev       Date:  2009-03       Impact factor: 25.468

5.  Aging and the brain renin-angiotensin system: relevance to age-related decline in cardiac function.

Authors:  Debra I Diz; Jasmina Varagic; Leanne Groban
Journal:  Future Cardiol       Date:  2008-05

6.  Knockout of the Na,K-ATPase α2-isoform in cardiac myocytes delays pressure overload-induced cardiac dysfunction.

Authors:  Tara N Rindler; Valerie M Lasko; Michelle L Nieman; Motoi Okada; John N Lorenz; Jerry B Lingrel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-02-22       Impact factor: 4.733

Review 7.  The brain and salt-sensitive hypertension.

Authors:  Frans H H Leenen; Marcel Ruzicka; Bing S Huang
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

8.  Knockout of the Na,K-ATPase α₂-isoform in the cardiovascular system does not alter basal blood pressure but prevents ACTH-induced hypertension.

Authors:  Tara N Rindler; Iva Dostanic; Valerie M Lasko; Michelle L Nieman; Jonathan C Neumann; John N Lorenz; Jerry B Lingrel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-19       Impact factor: 4.733

9.  Role of Na-K ATPase enzyme in vascular response of goat ruminal artery.

Authors:  K Kathirvel; S C Parija
Journal:  Indian J Pharmacol       Date:  2009-04       Impact factor: 1.200

Review 10.  Endogenous Ouabain: Recent Advances and Controversies.

Authors:  John M Hamlyn; Mordecai P Blaustein
Journal:  Hypertension       Date:  2016-07-25       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.